Over the past decade, one of the most important developments in genome editing has unfolded not only in the science itself, but in the way regulatory thinking has evolved alongside it.
For much of that time, conversations about genome editing centered on technical possibility: could precise genetic changes be made, and could those changes deliver meaningful improvements in how we produce food? Increasingly, the answer to both questions is yes. The more important question now is how these tools can be implemented responsibly, transparently and in ways that create real value for producers and for society.
That shift is evident in regulators’ and policymakers’ approach to genome editing. Regulatory frameworks are evolving, international dialogue is increasing, and the experience gained through early commercial applications is beginning to shape the next generation of regulatory thinking.
For aquaculture, this represents an important inflection point. The development of science- and risk-based regulatory frameworks may prove to be just as important to the future of genome editing as the scientific advances that made genome-editing solutions possible.
Science is Driving Regulatory Evolution
One of the most encouraging developments is the growing convergence in scientific thinking among regulators, even where legal frameworks remain different.
Policy makers continue to move at different speeds and within different legislative systems. However, the scientific questions underpinning regulatory evaluations are similar. Regulators are focusing more closely on the characteristics of the final product, the presence or absence of new DNA, and the resulting risk profile, rather than relying solely on the process used to develop the organism.
This distinction is particularly important for genome editing applications, where targeted genetic changes can mirror changes that may also arise naturally or through conventional breeding. Around the world, a growing number of jurisdictions have established differentiated regulatory pathways while maintaining meaningful oversight.
Recent developments in the European Union reinforce this broader direction of travel. Although current discussions on New Genomic Techniques and the EU Livestock Strategy do not establish regulatory pathways for genome edited animals, they clearly place innovation, competitiveness, resilience, animal health and food security at the center of future agricultural policy. Rather than prescribing individual technologies, they emphasize the outcomes agriculture must deliver. That creates an important context in which innovations, including genome editing, can be evaluated according to their scientific characteristics and the value they provide.
The most important point is not that countries are reaching identical regulatory outcomes. They are not. It is that they are increasingly asking the same scientific questions. That matters because shared scientific questions can create the foundation for more predictable, transparent and proportionate oversight.
From Technology to Solutions
This evolution in regulatory thinking reflects an equally important shift within the aquaculture industry itself.
The conversation is moving beyond genome editing as a technology and toward the practical breeding solutions it can help deliver. That distinction is important in our work because technology is never the point on its own. The question is whether it can help solve a real production, sustainability or animal health challenge.
Aquaculture is well positioned to benefit from genome editing because of its biological characteristics, including external fertilization, high fecundity and increasingly sophisticated breeding programs. More importantly, genome editing is being applied to traits that address priorities shared across the value chain, including reproductive sterility, resistance to pathogens, growth efficiency and yield improvement.
These are not simply demonstrations of technical capability. They are breeding solutions intended to deliver measurable value for producers, consumers, regulators and the environment.
Ultimately, the future of genome editing will depend on the value it creates and the confidence with which it can be introduced into real production systems.
Regulation as an Enabler of Innovation
One lesson emerging from early commercial genome editing programs is that regulation should not be viewed simply as a gateway to commercialization.
Evidence-led and proportionate regulatory frameworks are essential enablers of responsible innovation. They provide the predictability needed for investment, establish expectations for stewardship and transparency, and help build confidence among producers, supply chain partners and consumers that new technologies have undergone rigorous scientific evaluation.
Our experience working across multiple regulatory jurisdictions has reinforced this point. The conversation is beginning to mature. It is no longer only about how genome edited products should be regulated, but also about how regulatory systems can continue to evolve as practical implementation experience grows.
Like all science-based systems, genome editing regulatory frameworks should continue to develop alongside scientific understanding. Future discussions may increasingly focus on how oversight can remain proportionate to demonstrated risk while continuing to protect food safety, animal health and the environment. That balance is not always easy, but it is exactly where credible innovation depends on credible regulation.
The Next Chapter
Genome editing in aquaculture is no longer confined to research laboratories. Regulatory determinations for animal applications have been issued in multiple jurisdictions. Commercial breeding programs integrating genome editing are underway. International collaboration among regulators has never been stronger.
The first generation of commercial genome edited aquatic animals will do more than introduce new breeding technologies. They will establish regulatory precedent, build confidence across the seafood value chain, and begin to demonstrate how science- and risk-based regulation can enable responsible innovation.
Looking ahead, the next chapter for genome editing in aquaculture will be shaped not only by advances in molecular biology but by the industry’s ability to translate scientific progress into practical breeding solutions that deliver measurable value in commercial production systems.
The science has advanced. Regulatory systems are evolving. Commercial implementation has begun.
The opportunity now is to ensure they continue advancing together, with enough scientific rigour to earn trust and enough practical focus to make the innovation matter.
Written by:
Debbie Plouffe
Debbie provides regulatory guidance, supporting CAT clients to navigate and accelerate the responsible commercialization of genome editing in farmed aquatic species.